In this scenario, they found that higher Jagged1 membrane staining predicted poor overall survival of women with primary invasive HER2+ BC suggesting that the sequential blockade of HER2 and Jagged1 or Notch may be more effective than simultaneous blockade in terms of preventing drug resistance and tumor progression [94]. The gene discussed is ERBB2; the disease is breast cancer.